Mirza Shaheer Hyder: How Have Stroke-Related Dementia Deaths Changed Over The Last 2 Decades?
Mirza Shaheer Hyder, Sales And Marketing Intern at MedAngle, MBBS candidate at Dow University of Health Sciences, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”How have stroke-related dementia deaths changed over the last two decades?
I am excited to share my latest study, recently published in the Journal of Epidemiology and Global Health, which examines trends in dementia-associated mortality among stroke patients in the United States from 1999 to 2023.
Using the CDC WONDER database, our team analyzed over 250,000 death records of older adults.
While we found a 59 percent decrease in age-adjusted mortality rates over the last two decades, the burden remains significant.
Our findings highlight critical disparities, with higher mortality rates observed among females, Non-Hispanic Black individuals, and those living in non-metropolitan areas.
These results emphasize the urgent need for stroke-informed dementia care and a more equitable distribution of healthcare resources to support vulnerable populations.”
Title: Trends in Dementia Associated Mortality among Patients with Underlying Stroke: A Nationwide Retrospective Analysis (1999–2023)
Authors: Syed Tawassul Hassan, Syeda Lyba Onaiz, Shehdev Meghwar, Fatima Kaleem Ahmed, Mirza Shaheer Hyder, Syeda Kashaf Batool, Abdirizak Mohamud Yusuf
Read the Full Article on Journal of Epidemiology and Global Health
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 16, 2026, 07:26James Crowley, Professor of Medicine emeritus at Brown University, posted on LinkedIn:
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency